|
M6PR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.834800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.899780E-03 |
| Normal-vs-Stage2 |
2.075600E-02 |
| Normal-vs-Stage3 |
3.175300E-03 |
| Normal-vs-Stage4 |
1.525600E-02 |
| Stage1-vs-Stage2 |
7.317800E-01 |
| Stage1-vs-Stage3 |
6.082200E-01 |
| Stage1-vs-Stage4 |
9.960000E-01 |
| Stage2-vs-Stage3 |
9.809600E-01 |
| Stage2-vs-Stage4 |
7.870000E-01 |
| Stage3-vs-Stage4 |
7.164000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.321400E-03 |
| Normal-vs-AfricanAmerican |
4.435800E-01 |
| Normal-vs-Asian |
4.404500E-03 |
| Caucasian-vs-AfricanAmerican |
2.169200E-01 |
| Caucasian-vs-Asian |
5.481000E-01 |
| AfricanAmerican-vs-Asian |
1.075170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.771540E-04 |
| Normal-vs-Female |
1.320180E-02 |
| Male-vs-Female |
2.500400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.744200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.480230E-03 |
| Normal-vs-Age(61-80Yrs) |
5.182600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.913500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.404000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.071600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.927200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.785200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.914200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.602600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.749950E-01 |
| Classical-VS-Follicular |
2.634300E-02 |
| Classical-VS-Other |
3.745800E-01 |
| Classical-VS-Normal |
2.328200E-02 |
| Tall-VS-Follicular |
7.075600E-01 |
| Tall-VS-Other |
8.946000E-01 |
| Tall-VS-Normal |
3.163200E-03 |
| Follicular-VS-Other |
9.992800E-01 |
| Follicular-VS-Normal |
3.443100E-04 |
| Other-VS-Normal |
2.574400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.582270E-03 |
| Normal-vs-N1 |
4.00489999999865E-05 |
| N0-vs-N1 |
4.500100E-02 |
|
|
